Margaret Hamburg says selection process may move faster once Xavier Becerra is confirmed as HHS secretary since 'the chemistry of the relationship between the FDA commissioner and the HHS secretary is important.'
Two former US Food and Drug Administration leaders not only indicated that Acting Commissioner Janet Woodcock should become the next permanent agency leader, but argued that she is able make substantive moves at the FDA even while in the temporary role.
Robert Califf, who served as commissioner from February 2016 to January 2017, said 12 March during a webinar sponsored by...
Recent studies show that spaceflight can significantly weaken astronauts’ immune systems, making them more susceptible to infections and health complications during and after missions. Understanding these changes is crucial for ensuring the safety of future long-duration space travelers.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
Recent ODAC meetings suggest the FDA will expand focus beyond applications with pending approval decisions to refining trial designs and drug labels for competitors.
The US FDA Commissioner pushed for a rebalancing of the US’s pharmaceutical supply chains while also stressing that there is a role for US-China commerce that would be risky to compromise.
